ArticleInternational journal of molecular sciences2025
Validation of a New High-Throughput Cell Separation Method for Downstream Molecular Applications.
Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The development of new cell separation technologies has continued as the demand for sorted cell populations for molecular testing increases. The goal is to increase through-put potential and reduce the manual handling of samples required whilst ensuring that cells are sorted efficiently with high purity. Herein, we review two affinity-based methods utilising magnetic beads to isolate cells: one is currently used within a clinical laboratory as standard of care and the other is a newly developed larger platform using the same principle. Cells were sorted simultaneously on both platforms and assessments were made of the purity, cell recovery, and hands-on time, indicating that the new larger platform is sufficient for use in a clinical laboratory as it not only increased cell sorting capacity and reduced manual processing but was also able to isolate cells with sufficient purity levels for downstream molecular testing.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.